Diagnosis of Chagas' disease

Revista Latinoamericana de Microbiologia

Volumn 42, Issue 3, 2000, Pages 121-129

  Lopez Antunano F J ^a   Rangel Flores, H ^a   Ramos, C ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Chagas' disease; Diagnosis

Indexed keywords

CHAGAS DISEASE; CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; DISEASE TRANSMISSION; HUMAN; IMMUNE RESPONSE; LABORATORY DIAGNOSIS; PARASITE IDENTIFICATION; PRIMARY HEALTH CARE; REDUVIIDAE; REVIEW; TRYPANOSOMA CRUZI;

REDUVIIDAE; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0034476301     PISSN: 01874640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Hemocultivo como método de diagnóstico de la enfermedad de Chagas
2. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alphayl antibodies
3. Terapia da fase crónica da infecção experimental de Trypanosoma cruzi com benznidazole e nifurtimox
4. Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: Diagnosis of chronic Chagas' disease
5. Avian hematozoa from west-central Bolivia
6. Chagas disease in Virgem da Lapa, Minas Gerais, Brazil. IV. Clinical and epidemiological aspects of left ventricular aneurism
7. Immunity to Trypanosoma cruzi
8. Chemotherapy of Trypanosoma cruzi infections
9. Present status of chemotherapy and chemoprophylaxis of human trypanosomiasis in the Western Hemisphere
10. Biology of Trypanosoma cruzi
11. Direct identification of Trypanosoma cruzi natural clonesin vectors and mammalian hosts by polymerase chain reaction amplification
12. Inquérito sorológico da prevalencia da infeco da Doenca de Chagas no Brasil 1975/1980
13. Isolation of a Trypanosoma cruzi antigen by affinity chromatography with a monoclonal antibody. Preliminary evaluation of its possible applications in serological tests
14. Evolución clínico-parasitológica y tolerancia a la droga de 33 niños con infección chagásica crónica tratados con Bay 2502
15. I- (substituted) benzyl minoimidazole-4-carboxamides are potent orally active inhibitors of Trypanosoma cruzi in mice
16. lgG antibody reactivity with Trypanosoma cruzi and Leishmania antigens in sera of patients with Chagas' disease and leishmaniasis
17. Effect of actinomycin D on Trypanosoma cruzi
18. Cecilio Romaña, Romaña's sign and Chagas' disease
19. Trypanocidal activity and plasma kinetics ofcis-Pt(II) pentamidine intheparasitized sheep
20. Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor
21. El método de concentración de Stront en el diagnóstico de la fase aguda de la enfermedad de Chagas
22. Congenital Chagas' disease: Diagnostic and clinical aspects
23. Hemocultives from chronic chagasic patients using ADT or heparin as anticoagulants
24. American Trypanosomiasis and chronic Chagas a cardiopathy at the Ignacio Chavez National Institute of Cardiology
25. Isolation of a strain of Trypanosoma cruzi from a patient with chronic Chagas cardiomyopathy and its biological characterization
26. Da reacao de Bordet e Gengou na molestia de Carlos Chagas como elemento diagnostico
27. Laboratory acquired Chagas' disease
28. Shift of excretory-secretory immunogens of Trypanosoma cruzi during human Chagas' disease
29. Chagas' disease screening in blood bank employing enzyme immunoassay
30. Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies
31. Criterion of cure of human Chagas' disease after specific chemotherapy, recent advances
32. Use of recombinant antigens for the accurate immunodiagnosis of Chagas' disease
33. Specific and sensitive immunological diagnosis of Chagas' disease by competitive antibody enzyme immunoassay using a Trypanosoma cruzi-specific monoclonal antibody
34. Trypanosoma cruzi: A possible control of transfusion-induced Chagas' disease by phenolic antioxidants
35. Cardiac complications of American trypanosomiasis (Chagas disease). Various case reports and general observations
36. Quimioterapia de las infecciones producidas por Trypanosoma cruzi
37. Immunodetection of antibodies in sera from symptomatic and asymptomatic Chilean Chagas' disease patients with Trypanosoma cruzi recombinant antigens
38. Use of Trypanosoma cruzi defined proteins for diagnosis multicentre trial, serological and technical aspects
39. Purine analogs as chemotherapeutic agents in Leishmaniasis and American Trypanosomiasis
40. Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease
41. Hemoculture compared with xenodiagnosis for the detection of Trypanosoma cruzi infection in man and in animals
42. Neonatal Chagas disease: Laboratory diagnosis during the first year of life
43. Evaluation of three commercial enzyme-linked immunosorbent assays for diagnosis of Chagas' disease
44. Enfermedad de Chagas. Informe de un grupo de estudio
45. Control de la enfermedad de Chagas. Informe de un Comité de Expertos de la OMS
46. Trypanosoma cruzi: Cloning and expression of an antigen recognized by acute and chronic human chagasic sera
47. Xenodiagnóstico, hemocultura e teste de lise mediada pello complemento como critério de seleção de pacientes chagásicos crónicos para quimioterapia
48. Saliva ELISA: A method for the diagnosis of chronic Chagas disease in endemic areas
49. Supressor cells present in the spleens of Trypanosoma cruzi infected mice
50. Detection of antibodies against Trypanosoma cruzi in donors from a blood bank in Cuernavaca, Morelos, Mexico
51. Rendimiento del xenodiagnóstico en las formas agudas y congénitas de la enfermedad de Chagas
52. Valor el xenodiagnóstico en la infección chagásica crónica
53. Experienca terapéutica con el Bay 2502 en la infección chagásica crónica en el adulto. Importancia del uso adecuado del xenodiagnóstico
54. th England
55. Risk for transfusion-transmitted infectious diseases in Central and South America
56. Interruption of Chagas' disease transmission through vector elimination
57. Molecular and immunologic bases for the development of a vaccine against Chagas disease
58. Tratamiento especifico de la infección por Trypanosoma cruzi. Actualizaciones en la enfermedad de Chagas
59. Enhanced platelet adherence and aggregation in Chagas' disease: A potential pathogenic mechanism for cardiomyopathy
60. Trypanocidal nitroarene treatment of experimental Trypanosoma cruzi infection does not prevent progression of chronic phase heart lesions in rabbits
61. Isoenzyme variability of Trypanosoma cruzi, the agent of Chagas' Disease: Genetical, taxonomical and epidemiological significance
62. General procedure to construct highly specific kDNA probes for clones of Trypanosoma cruzi for sensitive detection by polymerase chain reaction
63. Serological methods in the diagnosis of Chagas' disease
64. Control of Chagas Disease. Report of a WHO Expert Committee
65. Dynamics of transmission of Trypanosoma cruzi in a rural area of Argentina. IV. Serologic, parasitologic and electrocardiographic study of the human population
66. Chagas' disease: An ecological appraisal with special emphasis on its insect vector
67. Trends of Trypanosoma cruzi infection based on data from blood bank screening
68. Mass screening for Trypanosoma cruzi infections using the immunofluorescence, ELISA and haemagglutination tests on serum samples and on blood eluates from filter-paper
69. Mucosal alterations in human chronic chagasic esophagopathy